Literature DB >> 8318484

Reduction in mydriatic drop size in premature infants.

S Wheatcroft1, A Sharma, J McAllister.   

Abstract

In a prospective study of 26 premature infants, 5 microliters microdrops were compared with standard 26 microliters eye drops of cyclopentolate 0.5% and phenylephrine 2.5%. There was no statistical difference in pupil dilatation. The 5 microliters microdrops have potentially fewer adverse effects in premature infants.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8318484      PMCID： PMC504531          DOI： 10.1136/bjo.77.6.364

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  11 in total

1.  Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant.

Authors:  C R Bauer; M C Trottier; L Stern
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

2.  Pupillary responses to mydriatic agents in premature infants.

Authors:  E F Carpel; R E Kalina
Journal:  Am J Ophthalmol       Date:  1973-06       Impact factor: 5.258

3.  Creating smaller eyedrops by reducing eyedropper tip dimensions.

Authors:  R H Brown; M L Hotchkiss; E B Davis
Journal:  Am J Ophthalmol       Date:  1985-04-15       Impact factor: 5.258

Review 4.  Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.

Authors:  R H Rengstorff; C B Doughty
Journal:  Am J Optom Physiol Opt       Date:  1982-02

5.  How safe are ocular drugs in pediatrics?

Authors:  E A Palmer
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

6.  The influence of drop size on pupil dilatation.

Authors:  R H Gray
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

7.  Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.

Authors:  B J Lees; L A Cabal
Journal:  Pediatrics       Date:  1981-08       Impact factor: 7.124

8.  Feeding intolerance following ophthalmologic examination.

Authors:  M C Hermansen; L S Sullivan
Journal:  Am J Dis Child       Date:  1985-04

9.  Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption.

Authors:  M G Lynch; R H Brown; S M Goode; R D Schoenwald; D S Chien
Journal:  Arch Ophthalmol       Date:  1987-10

10.  Systemic effects of mydriatics in low weight infants.

Authors:  T Rosales; S Isenberg; R Leake; S Everett
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1981 Nov-Dec       Impact factor: 1.402
View more
  9 in total

1.  Systemic effects of screening for retinopathy of prematurity.

Authors:  D E Laws; C Morton; M Weindling; D Clark
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Production and characterization of drug-loaded toroidal vortices from a novel ocular drug delivery device.

Authors:  Matthew J Herpin; Dominik Ebi; Noel T Clemens; Hugh D C Smyth
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Neurotoxic Effects of Topical Cyclopentolate.

Authors:  A Rajeev; G Gupta; K M Adhikari; A K Yadav; M Sathyamoorthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Alternative mydriasis techniques for retinopathy of prematurity screening.

Authors:  Aikaterini K Seliniotaki; Efthymia Prousali; Maria Lithoxopoulou; Stamatia Kokkali; Nikolaos Ziakas; Vasiliki Soubasi; Asimina Mataftsi
Journal:  Int Ophthalmol       Date:  2020-08-09       Impact factor: 2.031

5.  Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure.

Authors:  Yashwant Agrawal; Sandeep Patri; Jagadeesh K Kalavakunta; Vishal Gupta
Journal:  BMJ Case Rep       Date:  2016-07-28

6.  Severe hypertension and pulmonary edema associated with systemic absorption of topical phenylephrine in a child during retinal surgery.

Authors:  Ashraf A Abdelhalim; Mohamed Mostafa; Ahmed Abdulmomen; Essam A Othman
Journal:  Saudi J Anaesth       Date:  2012-07

7.  Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial.

Authors:  Onsiri Thanathanee; Tanapat Ratanapakorn; Michael G Morley; Yosanan Yospaiboon
Journal:  Clin Ophthalmol       Date:  2012-02-15

8.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09

9.  Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Authors:  Aikaterini K Seliniotaki; Anna-Bettina Haidich; Maria Lithoxopoulou; Helen Gika; Eleftheria Boutou; Christina Virgiliou; Martha Nikolaidou; Aristides Dokoumetzidis; Nikolaos Raikos; Elisavet Diamanti; Nikolaos Ziakas; Asimina Mataftsi
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.